LACTOSE (INDIA)
Back to Cashflow Statement
|
LACTOSE (INDIA) Last 5 Year Cash Flow from Operating Activities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Operating Activities | ₹8.78 Cr | ₹7.89 Cr | ₹8.47 Cr | ₹2.17 Cr | ₹7.41 Cr |
What is the latest Cash Flow from Operating Activities ratio of LACTOSE (INDIA) ?
Year | Cash Flow from Operating Activities |
---|---|
Mar2024 | ₹8.78 Cr |
Mar2023 | ₹7.89 Cr |
Mar2022 | ₹8.47 Cr |
Mar2021 | ₹2.17 Cr |
Mar2020 | ₹7.41 Cr |
How is Cash Flow from Operating Activities of LACTOSE (INDIA) Trending?
Years | Cash Flow from Operating Activities | % Change | |
---|---|---|---|
Mar2024 | ₹8.78 Cr | 11.17 | |
Mar2023 | ₹7.89 Cr | -6.78 | |
Mar2022 | ₹8.47 Cr | 291.09 | |
Mar2021 | ₹2.17 Cr | -70.79 | |
Mar2020 | ₹7.41 Cr | - |
Compare Cash Flow from Operating Activities of peers of LACTOSE (INDIA)
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
LACTOSE (INDIA) | ₹121.7 Cr | -3.8% | -3.5% | -41.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹394,115.0 Cr | 3.5% | -3.4% | -5.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹162,735.0 Cr | 3.7% | -10.2% | 25.6% | Stock Analytics | |
CIPLA | ₹126,313.0 Cr | 5.3% | 6.1% | -1.3% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹122,592.0 Cr | 1.4% | 4.6% | 7.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,095.0 Cr | 3.9% | 0% | -9.9% | Stock Analytics |
LACTOSE (INDIA) Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
LACTOSE (INDIA) | -3.8% |
-3.5% |
-41.1% |
SENSEX | -0% |
-2.4% |
1.2% |
You may also like the below Video Courses